Li Loong Loh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Li Loong Loh has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Hong Seok Kim
Department of Orthopedic Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Republic of Korea
2 shared publications - Sang Yoon Kang
Department of Orthopedic Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Republic of Korea
2 shared publications - Jeong Joon Yoo
Department of Orthopedic Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
1 shared publication Mohamed Saufi Awang
Department of Neurosurgery, Islamic International University Malaysia Medical Centre, Kuantan, Pahang, Malaysia
1 shared publicationMuhammad Wafiuddin
Department of Surgery, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Sabah, Malaysia
1 shared publicationZamzuri Zakaria Mohamad
Department of Neurosurgery, Islamic International University Malaysia Medical Centre, Kuantan, Pahang, Malaysia
1 shared publication
Latest Publications
- Open Access
- 14 April 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (8) , 2965
Complications and Mortality of Open Reduction and Internal Fixation for Periprosthetic Femoral Fractures Around Cementless Femoral Stems: A Mid- to Long- Term Retrospective Cohort Study
Background/Objectives: The optimal treatment strategy for periprosthetic femoral fractures (PFFs) around cementless femoral stems remains controversial, particularly for fractures in which stem stability is difficult to determine preoperatively. While revision arthroplasty is often recommended for unstable stems, open reduction and internal fixation (ORIF) continues to be widely used in clinical practice. This study aimed to evaluate mid- to long-term clinical outcomes, complications, and mortality of ORIF for PFFs around cementless stems. Methods: We retrospectively reviewed patients who underwent ORIF for PFFs around cementless femoral stems at a single tertiary referral center between March 2002 and March 2021. Clinical and radiographic outcomes, complications, reoperation, and mortality were assessed. Kaplan–Meier survival analysis was performed to estimate the survival rates for being free of revision and reoperation. Results: A total of 53 patients were included, with a mean follow-up of 4.4 years (range, 1.0 to 19.6). The mean age was 71.0 years, and 30 patients (56.6%) were female. Most fractures were Vancouver type B1 (84.9%). Radiographic union was achieved in 51 patients (96.2%), with a mean time to union of 20.5 weeks. The estimated revision-free survival was 98.1% (95% CI, 87.4–99.7%), and the reoperation-free survival rate was 94.3% (95% CI, 83.5–98.1%) at 5 years. The one- and five-year mortality rates were 5.7% and 22.6%, respectively. Conclusions: Open reduction and internal fixation for PFFs around cementless stems demonstrated acceptable mid- to long-term outcomes with comparable survivorship in selected patients. Although reoperations were not uncommon, mortality rates were comparable. ORIF may represent a reasonable treatment option in carefully selected patients, particularly those with high surgical risk. However, as the cohort was predominantly composed of B1 fractures, the findings should be interpreted primarily in the context of this fracture subtype.
- 14 April 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (8) , 2965
Open AccessComplications and Mortality of Open Reduction and Internal Fixation for Periprosthetic Femoral Fractures Around Cementless Femoral Stems: A Mid- to Long- Term Retrospective Cohort Study
Background/Objectives: The optimal treatment strategy for periprosthetic femoral fractures (PFFs) around cementless femoral stems remains controversial, particularly for fractures in which stem stability is difficult to determine preoperatively. While revision arthroplasty is often recommended for unstable stems, open reduction and internal fixation (ORIF) continues to be widely used in clinical practice. This study aimed to evaluate mid- to long-term clinical outcomes, complications, and mortality of ORIF for PFFs around cementless stems. Methods: We retrospectively reviewed patients who underwent ORIF for PFFs around cementless femoral stems at a single tertiary referral center between March 2002 and March 2021. Clinical and radiographic outcomes, complications, reoperation, and mortality were assessed. Kaplan–Meier survival analysis was performed to estimate the survival rates for being free of revision and reoperation. Results: A total of 53 patients were included, with a mean follow-up of 4.4 years (range, 1.0 to 19.6). The mean age was 71.0 years, and 30 patients (56.6%) were female. Most fractures were Vancouver type B1 (84.9%). Radiographic union was achieved in 51 patients (96.2%), with a mean time to union of 20.5 weeks. The estimated revision-free survival was 98.1% (95% CI, 87.4–99.7%), and the reoperation-free survival rate was 94.3% (95% CI, 83.5–98.1%) at 5 years. The one- and five-year mortality rates were 5.7% and 22.6%, respectively. Conclusions: Open reduction and internal fixation for PFFs around cementless stems demonstrated acceptable mid- to long-term outcomes with comparable survivorship in selected patients. Although reoperations were not uncommon, mortality rates were comparable. ORIF may represent a reasonable treatment option in carefully selected patients, particularly those with high surgical risk. However, as the cohort was predominantly composed of B1 fractures, the findings should be interpreted primarily in the context of this fracture subtype.
- Open Access
- 28 November 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (23) , 8449
Impact of Branched-Chain Amino Acid Supplementation on Postoperative Serum Albumin Recovery in Older Adults with Hip Fracture: A Propensity Score-Matched Study
Background/Objectives: Hip fracture patients commonly exhibit impaired nutritional status, including low serum albumin levels related to sarcopenia, which may affect recovery. This study evaluated the effect of branched-chain amino acid (BCAA) supplementation on serum albumin levels in hip fracture patients. Methods: This retrospective analysis was conducted at a single tertiary referral center on a cohort of patients with hip fractures including femoral neck and intertrochanteric fractures who visited the emergency department between January 2022 and November 2023. After propensity score matching, 106 patients were analyzed (BCAA: n = 53; control: n = 53); prior to matching, 67 treated and 110 control patients were eligible. Patients receiving BCAA supplementation were administered three times daily for six weeks postoperatively and they were matched with controls based on clinical and demographic variables. Controls received standard perioperative care without BCAA supplementation, and no placebo was administered. Serum albumin levels were measured before the surgery and 6 weeks postoperatively. After propensity score matching, 53 patients from each cohort were analyzed. The primary outcome was the difference in serum albumin levels; secondary outcomes were the length of hospital stay (LOS), blood transfusions (Tf), and the incidence of delirium. Results: The matched cohorts exhibited comparable baseline characteristics. Analysis revealed a significant increase in serum albumin levels among patients who received BCAA supplementation compared to the matched control group. No differences were found in terms of LOS, Tf, and the incidence of delirium during the index admission. Conclusions: This preliminary study suggests a potential positive effect of BCAA supplementation on serum albumin levels in patients with hip fractures. Further prospective investigations with larger sample sizes are warranted to validate these findings and elucidate the clinical implications for nutritional support in this population.
- 28 November 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (23) , 8449
Open AccessImpact of Branched-Chain Amino Acid Supplementation on Postoperative Serum Albumin Recovery in Older Adults with Hip Fracture: A Propensity Score-Matched Study
Background/Objectives: Hip fracture patients commonly exhibit impaired nutritional status, including low serum albumin levels related to sarcopenia, which may affect recovery. This study evaluated the effect of branched-chain amino acid (BCAA) supplementation on serum albumin levels in hip fracture patients. Methods: This retrospective analysis was conducted at a single tertiary referral center on a cohort of patients with hip fractures including femoral neck and intertrochanteric fractures who visited the emergency department between January 2022 and November 2023. After propensity score matching, 106 patients were analyzed (BCAA: n = 53; control: n = 53); prior to matching, 67 treated and 110 control patients were eligible. Patients receiving BCAA supplementation were administered three times daily for six weeks postoperatively and they were matched with controls based on clinical and demographic variables. Controls received standard perioperative care without BCAA supplementation, and no placebo was administered. Serum albumin levels were measured before the surgery and 6 weeks postoperatively. After propensity score matching, 53 patients from each cohort were analyzed. The primary outcome was the difference in serum albumin levels; secondary outcomes were the length of hospital stay (LOS), blood transfusions (Tf), and the incidence of delirium. Results: The matched cohorts exhibited comparable baseline characteristics. Analysis revealed a significant increase in serum albumin levels among patients who received BCAA supplementation compared to the matched control group. No differences were found in terms of LOS, Tf, and the incidence of delirium during the index admission. Conclusions: This preliminary study suggests a potential positive effect of BCAA supplementation on serum albumin levels in patients with hip fractures. Further prospective investigations with larger sample sizes are warranted to validate these findings and elucidate the clinical implications for nutritional support in this population.
- Open Access
- 31 January 2022
- Published by Universiti Malaysia Sabah (UMS) in Borneo Journal of Medical Sciences (BJMS)
- Vol. 16 (1) , 57-62
Partial Cyst Resection, Fabrication, Imbrication and Duraplasty of Symptomatic Sacral Tarlov Cysts
Tarlov cysts are pathological cerebrospinal fluid-filled sacs located in the space between the perineum and endoneurium of the nerve roots. Symptomatic Tarlov cysts are extremely rare. There is no consensus regarding the optimal surgical treatment for it up to date. We encountered a recurrent symptomatic sacral Tarlov cyst of a patient whose symptoms resolved after undergoing partial cyst resection, fabrication, imbrication, and duraplasty of sacral Tarlov cysts. A 53-year-old man was initially presented with worsening lower back and buttock region pain, sensory changes involving S1 – S3 distribution of the left lower limb in 2014. The initial magnetic resonance imaging (MRI) lumbosacral had been carried out and revealed a perineural cyst at the level of S1 – S3. The patient did S1 – S3 laminectomy, fabrication, and imbrication after failed conservative treatment and his symptoms resolved for three years. However, similar symptoms recurred in 2017 and the repeated MRI revealed a recurrent well-defined multiloculated cystic structure was seen arising from the spinal canal of S1 – S3 level. The second time, the patient underwent laminectomy S1 – S3, partial cyst resection, fabrication, imbrication, and duraplasty of the sacral region. Many proposed surgical options are available for treating the symptomatic Tarlov cysts. There is no literature reviewed on the best surgical option for the recurrent symptomatic Tarlov cyst. We proposed sacral laminectomy, partial cyst resection, imbrication, fat graft packing, fabrication, and duraplasty in recurrent symptomatic sacral Tarlov cyst.
- 31 January 2022
- Published by Universiti Malaysia Sabah (UMS) in Borneo Journal of Medical Sciences (BJMS)
- Vol. 16 (1) , 57-62
Open AccessPartial Cyst Resection, Fabrication, Imbrication and Duraplasty of Symptomatic Sacral Tarlov Cysts
Tarlov cysts are pathological cerebrospinal fluid-filled sacs located in the space between the perineum and endoneurium of the nerve roots. Symptomatic Tarlov cysts are extremely rare. There is no consensus regarding the optimal surgical treatment for it up to date. We encountered a recurrent symptomatic sacral Tarlov cyst of a patient whose symptoms resolved after undergoing partial cyst resection, fabrication, imbrication, and duraplasty of sacral Tarlov cysts. A 53-year-old man was initially presented with worsening lower back and buttock region pain, sensory changes involving S1 – S3 distribution of the left lower limb in 2014. The initial magnetic resonance imaging (MRI) lumbosacral had been carried out and revealed a perineural cyst at the level of S1 – S3. The patient did S1 – S3 laminectomy, fabrication, and imbrication after failed conservative treatment and his symptoms resolved for three years. However, similar symptoms recurred in 2017 and the repeated MRI revealed a recurrent well-defined multiloculated cystic structure was seen arising from the spinal canal of S1 – S3 level. The second time, the patient underwent laminectomy S1 – S3, partial cyst resection, fabrication, imbrication, and duraplasty of the sacral region. Many proposed surgical options are available for treating the symptomatic Tarlov cysts. There is no literature reviewed on the best surgical option for the recurrent symptomatic Tarlov cyst. We proposed sacral laminectomy, partial cyst resection, imbrication, fat graft packing, fabrication, and duraplasty in recurrent symptomatic sacral Tarlov cyst.